Gland Pharma Ltd - 543245 - Result Of Postal Ballot
Result of Postal Ballot21-04-2022
Gland Pharma Ltd - 543245 - Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2022
Certificate pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 202219-04-2022
Gland Pharma Ltd - 543245 - Compliance Certificate For The Period Ended 31-March-2022
Compliance certificate for the period ended 31-March-2022 issued by the Compliance officer and RTA of the Company under Reg 7(3) of the SEBI LODR.15-04-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call - Q4FY2205-04-2022
Gland Pharma Ltd - 543245 - Board Meeting Intimation for Audited Financial Results
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 202204-04-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of the meeting31-03-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of meetings28-03-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of meetings23-03-2022